Suerie Moon

5.1k total citations
69 papers, 1.8k citations indexed

About

Suerie Moon is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Organizational Behavior and Human Resource Management. According to data from OpenAlex, Suerie Moon has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Economics and Econometrics, 19 papers in Public Health, Environmental and Occupational Health and 15 papers in Organizational Behavior and Human Resource Management. Recurrent topics in Suerie Moon's work include Pharmaceutical Economics and Policy (19 papers), Global Public Health Policies and Epidemiology (14 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Suerie Moon is often cited by papers focused on Pharmaceutical Economics and Policy (19 papers), Global Public Health Policies and Epidemiology (14 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Suerie Moon collaborates with scholars based in United States, Switzerland and United Kingdom. Suerie Moon's co-authors include Julio Frenk, Ellen ‘t Hoen, Brenda Waning, Jonathan Berger, Alexandra Calmy, Steven G. Morgan, William C. Clark, Lawrence O. Gostin, Octavio Gómez‐Dantés and Elodie Jambert and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Suerie Moon

61 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suerie Moon United States 24 645 450 343 326 324 69 1.8k
Amir Attaran Canada 22 699 1.1× 797 1.8× 144 0.4× 605 1.9× 1.1k 3.3× 119 2.8k
Gerrit Van der Waldt South Africa 18 469 0.7× 270 0.6× 514 1.5× 644 2.0× 188 0.6× 101 2.3k
Johanna Hanefeld United Kingdom 27 433 0.7× 440 1.0× 236 0.7× 1.1k 3.5× 368 1.1× 91 2.7k
Jeffrey E. Harris United States 22 692 1.1× 197 0.4× 144 0.4× 411 1.3× 248 0.8× 72 2.1k
Karen A. Grépin United States 29 454 0.7× 278 0.6× 125 0.4× 619 1.9× 312 1.0× 111 2.4k
Marjolein Zweekhorst Netherlands 28 226 0.4× 189 0.4× 81 0.2× 513 1.6× 389 1.2× 98 2.0k
Jim Yong Kim United States 17 370 0.6× 240 0.5× 166 0.5× 443 1.4× 1.3k 3.9× 65 2.3k
Allyson M Pollock United Kingdom 33 1.1k 1.6× 529 1.2× 176 0.5× 1.3k 4.1× 180 0.6× 228 3.9k
Gavin Yamey United States 26 443 0.7× 819 1.8× 282 0.8× 846 2.6× 467 1.4× 189 3.3k
Jillian Clare Köhler Canada 22 466 0.7× 280 0.6× 83 0.2× 162 0.5× 63 0.2× 82 1.2k

Countries citing papers authored by Suerie Moon

Since Specialization
Citations

This map shows the geographic impact of Suerie Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suerie Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suerie Moon more than expected).

Fields of papers citing papers by Suerie Moon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suerie Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suerie Moon. The network helps show where Suerie Moon may publish in the future.

Co-authorship network of co-authors of Suerie Moon

This figure shows the co-authorship network connecting the top 25 collaborators of Suerie Moon. A scholar is included among the top collaborators of Suerie Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suerie Moon. Suerie Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yiqi, et al.. (2025). Beyond resistance: alternative innovation models for global access and stewardship of new antibiotics. Humanities and Social Sciences Communications. 12(1).
2.
Moon, Suerie, et al.. (2025). Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change. Journal of Pharmaceutical Policy and Practice. 18(1). 2436899–2436899. 2 indexed citations
3.
4.
Moon, Suerie, et al.. (2025). Do costs, timeframes and attrition rates differ between non-commercial and commercial biomedical R&D ? A study of neglected diseases R&D and the P2I model. Graduate Institute Geneva Institutional Repository (Graduate Institute of International and Development Studies).
5.
Moon, Suerie, et al.. (2025). The 30-year evolution of oral cholera vaccines: A case study of a collaborative network alternative innovation model. PLOS Global Public Health. 5(1). e0003599–e0003599. 1 indexed citations
6.
Moon, Suerie, et al.. (2024). Alternative Pharmaceutical Innovation Models in Competitive Markets: A Collaborative Approach to Develop a Novel Drug for Hepatitis C. Tropical Medicine and Infectious Disease. 9(10). 233–233.
7.
Moon, Suerie, et al.. (2023). Pharmaceutical policy and innovation for rare diseases: A narrative review. F1000Research. 12. 211–211.
8.
Liu, Yiqi, et al.. (2023). Rising pharmaceutical innovation in the Global South: a landscape study. Journal of Pharmaceutical Policy and Practice. 16(1). 155–155. 3 indexed citations
9.
Moon, Suerie, et al.. (2023). Pharmaceutical policy and innovation for rare diseases: A narrative review. F1000Research. 12. 211–211. 6 indexed citations
10.
Gostin, Lawrence O., Eric Friedman, & Suerie Moon. (2019). Wealthy Countries Should Share Vaccine Doses Before It Is Too Late: The Greater Good Depends on Ending the Pandemic Everywhere. eYLS (Yale Law School). 1 indexed citations
11.
Ottersen, Trygve, et al.. (2017). Development Assistance for Health: What Criteria Do Multi-and-Bilateral Funders Use?. SSRN Electronic Journal. 1 indexed citations
12.
Moon, Suerie, et al.. (2017). Development Assistance for Health: Critiques, Proposals and Prospects for Change. SSRN Electronic Journal.
13.
Juneja, Sandeep, Aastha Gupta, Suerie Moon, & Stephen Resch. (2017). Projected Savings Through Public Health Voluntary Licences of HIV Drugs Negotiated By The Medicines Patent Pool (MPP). SSRN Electronic Journal. 1 indexed citations
14.
Anadón, Laura Díaz, Gabriel Chan, Alicia G. Harley, et al.. (2016). Making technological innovation work for sustainable development. Proceedings of the National Academy of Sciences. 113(35). 9682–9690. 140 indexed citations
15.
Gostin, Lawrence O., Oyewale Tomori, Suwit Wibulpolprasert, et al.. (2016). Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola. PLoS Medicine. 13(5). e1002042–e1002042. 62 indexed citations
16.
Moon, Suerie. (2015). Global Health Law: What, When and for What Purpose?: A Commentary on Lawrence Gostin's Global Health Law. SSRN Electronic Journal.
17.
Moon, Suerie. (2015). Governance Challenges in Global Health. SSRN Electronic Journal. 1 indexed citations
18.
Anadón, Laura Díaz, Kira Matus, Suerie Moon, et al.. (2014). Innovation and access to technologies for sustainable development: diagnosing weaknesses and identifying interventions in the Transnational Arena. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 1 indexed citations
19.
Moon, Suerie, Rafael Bermúdez, & Ellen ‘t Hoen. (2012). Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?. PLoS Medicine. 9(5). e1001218–e1001218. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026